The forecast for the sold production of human blood, animal blood prepared for therapeutic, prophylactic, or diagnostic uses, cultures of micro-organisms, and toxins in the UK shows a steady upward trend from 2024 to 2028, with values increasing from 575.07 million euros in 2024 to 621.25 million euros in 2028.
The year-on-year growth rates reveal a consistent growth in this sector: 2.06% from 2024 to 2025, 1.99% from 2025 to 2026, 1.91% from 2026 to 2027, and 1.83% from 2027 to 2028. The compound annual growth rate (CAGR) from 2024 to 2028 is approximately 1.94%.
Future trends to watch:
- Increased demand for biological products in healthcare and pharmaceuticals.
- Pioneering biotechnologies influencing market growth.
- Regulatory changes and innovation driving transformation.
